Annual ReportFiscal Year Ended Mar. 31, 2014
- Our Business Domain and Key Technologies / Medium-Term Vision / Advances in the Two Years Since the Institution of the New Management Team
- Financial Highlights
- Interview with the President
- Past, Present, and Future of Olympus- Conversation with Analysts
- Special Feature (Medical): Reliable Growth in Global Markets
- At a Glance
- Review of Business Segments (Medical Business / Scientific Solutions Business / Imaging Business)
- Intellectual Property Report
- To Our Stakeholders (Message from the Chairman)
- Corporate Governance
- Conversation between Outside Directors
- Olympus CSR
- Management Structure
- Financial Section (Financial Summary / Message from the Director in Charge of Finance / Analysis of Business Results, Financial Position, and Cash Flows / Risk Information / Consolidated Financial Statements and Notes / Independent Auditor's Report / Other Financial Data)
- Olympus Group Companies / Corporate Information
- FY Ended Mar. 31, 2025
- FY Ended Mar. 31, 2024
- FY Ended Mar. 31, 2023
- FY Ended Mar. 31, 2022
- FY Ended Mar. 31, 2021
- FY Ended Mar. 31, 2020
- FY Ended Mar. 31, 2019
- FY Ended Mar. 31, 2018
- FY Ended Mar. 31, 2017
- FY Ended Mar. 31, 2016
- FY Ended Mar. 31, 2015
- FY Ended Mar. 31, 2014
- FY Ended Mar. 31, 2013
- FY Ended Mar. 31, 2012